AMRX · Amneal Pharmaceuticals, Inc. · Proposed Sales
$21.38
-0.32 (-1.47%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.45B
Shares
348.41M
Volume · Nov 13
1.72M
Avg daily vol (3M)
3.17M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-11 | BUCHI J KEVIN | Director | 168,573 | 2026-08-11 | Charles Schwab Corp |
| 2025-11-17 | Nark Ted C | Director | 50,000 | 2025-11-17 | Charles Schwab Corp. |
| 2025-11-12 | NIKITA SHAH | OFFICER | 131,856 | 2025-11-12 | MERRILL LYNCH |
| 2025-08-27 | Kiely John | Director | 32,000 | 2025-08-27 | MERRILL LYNCH |
| 2025-08-22 | Shah Nikita | Officer | 36,796 | 2025-08-22 | MERRILL LYNCH |
| 2025-08-22 | Shah Nikita | Officer | 84,036 | 2025-08-22 | Charles Schwab Corp. |
| 2025-08-20 | BOYER ANDREW S | Officer | 104,244 | 2025-08-20 | Charles Schwab Corporation |
| 2025-08-20 | BOYER ANDREW S | Officer | 175,000 | 2025-08-20 | MERRILL LYNCH |
| 2025-08-15 | Konidaris Tasos | Officer | 219,159 | 2025-08-15 | Charles Schwab Corp. |
| 2025-08-14 | Shah Nikita | Officer | 71,694 | 2025-08-14 | MERRILL LYNCH |
| 2025-08-13 | Konidaris Tasos | Officer | 111,635 | 2025-08-13 | Charles Schwab Corp. |
| 2025-08-13 | Konidaris Tasos | Officer | 169,206 | 2025-08-13 | Charles Schwab Corp. |
| 2025-08-12 | Daly Jason B. | Officer | 22,000 | 2025-08-12 | MERRILL LYNCH |
| 2025-08-12 | Shah Nikita | Officer | 50,000 | 2025-08-12 | Charles Schwab Corp. |
| 2025-08-12 | BOYER ANDREW S | Officer | 33,436 | 2025-08-12 | Charles Schwab Corporation |
| 2025-05-16 | Shah Nikita | Officer | 49,140 | 2025-05-16 | MERRILL LYNCH |
| 2025-05-12 | Kiely John | Director | 50,000 | 2025-05-12 | MERRILL LYNCH |
| 2025-05-02 | Gautam Patel | Director | 160,000 | 2025-05-02 | J.P. Morgan Securities LLC |
| 2025-03-14 | Patel Tushar Bhikhubhai | 10% Stockholder | 5,000,000 | 2025-03-14 | Citigroup Global Markets Inc |
| 2025-03-05 | BOYER ANDREW S | Officer | 125,000 | 2025-03-05 | MERRILL LYNCH |
| 2025-03-05 | Daly Jason B. | Officer | 90,000 | 2025-03-05 | MERRILL LYNCH |
| 2025-03-05 | Konidaris Tasos | Officer | 100,000 | 2025-03-05 | Charles Schwab & Co., Inc. |
| 2025-03-05 | Alva Emily Peterson | Director | 85,000 | 2025-03-05 | MERRILL LYNCH |
| 2025-01-02 | Gautam J Patel | Director | 320,000 | 2025-01-02 | J.P. Morgan Securities LLC |
| 2024-11-22 | Kiely John | Director | 17,058 | 2024-11-22 | MERRILL LYNCH |
| 2024-11-21 | Autor Deborah M. | Director | 50,000 | 2024-11-21 | MERRILL LYNCH |
| 2024-11-15 | Daly Jason B. | Officer | 57,322 | 2024-11-15 | MERRILL LYNCH |
| 2024-08-14 | Shah Nikita | Officer | 70,000 | 2024-08-14 | MERRILL LYNCH |
| 2024-08-14 | Shah Nikita | Officer | 30,000 | 2024-08-14 | Charles Schwab Corp |
| 2024-08-14 | BOYER ANDREW S | Officer | 70,000 | 2024-08-14 | MERRILL LYNCH |
| 2024-05-16 | Autor Deborah M. | Director | 38,000 | 2024-05-16 | MERRILL LYNCH |
| 2023-08-11 | BOYER ANDREW S | Director | 21,000 | 2023-08-11 | Charles Schwab Corporation |
| 2023-08-11 | BOYER ANDREW S | Officer | 8,302 | 2023-08-11 | MERRILL LYNCH |
Showing 1–33 of 33 filings
Key facts
CIK
1723128
CUSIP
03168L105
13F (30d)
266 filings
242 filers
Visit website
Investor relations